Farmers & Merchants Investments Inc’s Cytokinetics CYTK Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.75K	Hold	91	–	–	﹤0.01%	881
2026 Q1	$6K	Hold	91	–	–	﹤0.01%	926
2025 Q4	$5.78K	Hold	91	–	–	﹤0.01%	914
2025 Q3	$5K	Buy	91 +5	+6%	+$206	﹤0.01%	975
2025 Q2	$2.84K	Buy	86 +15	+21%	+$522	﹤0.01%	1112
2025 Q1	$2.85K	Buy	71 +35	+97%	+$1.61K	﹤0.01%	1090
2024 Q4	$1.69K	Hold	36	–	–	﹤0.01%	1255
2024 Q3	$1.9K	Hold	36	–	–	﹤0.01%	1212
2024 Q2	$1.95K	Hold	36	–	–	﹤0.01%	1155
2024 Q1	$2.52K	Sell	36 -35	-49%	-$2.71K	﹤0.01%	1003
2023 Q4	$5.93K	Hold	71	–	–	﹤0.01%	726
2023 Q3	$2.09K	Hold	71	–	–	﹤0.01%	1004
2023 Q2	$2.32K	Hold	71	–	–	﹤0.01%	1011
2023 Q1	$2.5K	Buy	71 +5	+8%	+$204	﹤0.01%	938
2022 Q4	$3.02K	Buy	66 +3	+5%	+$129	﹤0.01%	898
2022 Q3	$3K	Sell	63 -45	-42%	-$2.17K	﹤0.01%	839
2022 Q2	$4K	Hold	108	–	–	﹤0.01%	878
2022 Q1	$4K	Hold	108	–	–	﹤0.01%	898
2021 Q4	$5K	Hold	108	–	–	﹤0.01%	890
2021 Q3	$4K	Sell	108 -50	-32%	-$1.47K	﹤0.01%	871
2021 Q2	$3K	Hold	158	–	–	﹤0.01%	833
2021 Q1	$4K	Buy	+158	New	+$3.37K	﹤0.01%	792

Other funds holding CYTK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Farmers & Merchants Investments Inc's CYTK Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Cytokinetics (CYTK) position steady in Q2 2026 at 91 shares worth $7.75K. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Farmers & Merchants Investments Inc first reported a position in CYTK in Q1 2021 and has held it in 22 quarters since. 250 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Farmers & Merchants Investments Inc held 91 shares of Cytokinetics worth $7.75K as of Q2 2026.
Farmers & Merchants Investments Inc left its Cytokinetics share count unchanged in Q2 2026.
Cytokinetics made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #881 holding.
Farmers & Merchants Investments Inc first reported a position in Cytokinetics in Q1 2021 and has held it in 22 quarters since.
250 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.